April 2, 2012
GlaxoSmithKline K.K. (GSK) and Dainippon Sumitomo Pharma (DSP) started copromotion in Japan on April 1 of GSK’s antidepressant Paxil CR Tablets 12.5 mg and 25 mg (paroxetine HCl hydrate), which were approved in Japan in January 2012. GSK is responsible...read more